Investor Video

Watch our recorded Opal Information Session about the 2023 Capital Raise

Information Memorandum

For the capital raising of $2.5m through the issue of 10,000,000 new Shares at $0.25 (25 cents) per Share together with one (1) free attaching Option for every one (1) new Share having an exercise price of $0.25 (25 cents)

$5m WA Grant

Opal Biosciences awarded Investment Attraction Fund grant by WA government

Strategic Acquisition and Capital Raise: offering 10,000,000 shares at $0.25 each to raise $2.5 million: prerequisite for the share-based acquisition of Formulytica Pty Ltd, a growing revenue-generating business based in Melbourne, enhancing Opal’s capabilities and market reach.

Government Support: $5 million grant by the WA government to establish a pharmaceutical manufacturing facility in Perth, further solidifying its market position.

Innovative Focus: The new facility will produce sterile liquid pharmaceutical products suitable for personalized medicine, such as patient-specific cancer vaccines, and clinical trial supplies. This addresses a growing need in the Australian pharmaceutical market.

Intellectual Property and Expertise: grow its in-house intellectual property portfolio. Formulytica brings specialized expertise in pharmaceutical development, creating a valuable platform for the merged entity.

Diverse Clientele and Strong Shareholder Base: international/local companies and medical research groups. 

Experienced Leadership: The board and management team have significant experience in capital raising, acquisitions, and exits, ensuring that the company is well-positioned to execute its growth plans effectively.

Global Market Opportunity: The company aims to meet the significantly increased requirement for onshore manufacturing in Australia, driven by growth in clinical trials and the evolving market for personalized medicines. This positions Opal to capture a substantial market share both locally and internationally.

These investment highlights make Opal Biosciences an attractive opportunity for investors looking for growth and innovation in the pharmaceutical sector.

Opal BioSciences Information Memorandum

Opal capital raise for growth strategy | IM Announcement

Find us at the office

Opal Biosciences Ltd
Level 4, 100 Albert Road
South Melbourne
Victoria 3205

Opal Biosciences Ltd

ACN 605 631 963

Telephone: + 61 3 9692 7240
Facsimile: + 61 3 9077 9233

Twitter: @Opalbiosciences

Contact Us